While the broader market remains hesitant, professional money managers are making notable moves in Altria Group. The tobacco giant continues to face declining core revenue and a weak technical chart pattern. However, recent filings reveal that major institutional players are using the current share price weakness as a strategic entry point, raising questions about a potential value opportunity that retail investors might be overlooking.
The Dividend and Capital Return Appeal
For income-focused shareholders, Altria’s shareholder return policy remains a primary attraction. The company recently increased its quarterly dividend to $1.06 per share, translating to an annual yield of approximately 7.3%. This aggressive distribution is further supported by a share repurchase program authorized for $2.0 billion, a clear mechanism for returning excess liquidity to owners.
A Fundamental Mixed Bag
The company’s latest financial results present a dichotomy that explains prevailing investor skepticism. For the third quarter, adjusted earnings per share came in at $1.45, surpassing analyst forecasts. Conversely, revenue of $5.25 billion fell short of expectations, with a 3.0% decline highlighting the persistent headwinds in the traditional tobacco business.
Management has provided a stable forward outlook, narrowing its full-year 2025 earnings guidance to a range of $5.37 to $5.45 per share. This points to moderate growth of up to 5% compared to the prior year, offering investors clarity regarding the firm’s ongoing profitability.
Should investors sell immediately? Or is it worth buying Altria?
Significant Institutional Buys
Recent transaction disclosures underscore substantial interest from prominent funds. Fisher Asset Management boosted its stake in Altria by about 31.5%, bringing its total holding to nearly 97,400 shares. Market observers interpret this significant accumulation during a period of share price consolidation as a signal that large investors perceive fundamental value at current levels, irrespective of short-term market sentiment and technical challenges.
Technical Hurdles Persist
Despite the fundamental arguments, the stock’s chart remains under pressure. Shares currently trade at €49.84, positioned notably below the key 50-day and 200-day moving averages. The distance to the 52-week high of €58.32 now exceeds 14%.
The scenario has evolved into a contest between robust cash generation and a persistent technical downtrend. Analyst opinions are divided: while firms like Stifel maintain significantly higher price targets, UBS advises caution. A sustainable recovery likely hinges on the stock’s ability to reclaim the technical resistance zone around the moving averages, approximately €52 to €53, in the coming weeks.
Ad
Altria Stock: Buy or Sell?! New Altria Analysis from December 6 delivers the answer:
The latest Altria figures speak for themselves: Urgent action needed for Altria investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 6.
Altria: Buy or sell? Read more here...
